Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Skin Cancer01:30

Skin Cancer

3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Vaccines01:30

Cancer Vaccines

338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.9K
Overview
66.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Assessment of the Correlation Between 'COVID Toes' Search Volume and COVID-19 Case Incidence and Mortality Dynamics: A Longitudinal Data-Driven Approach.

Journal of the American Podiatric Medical Association·2026
Same author

Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer.

Critical reviews in oncology/hematology·2026
Same author

Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer.

Anticancer research·2026
Same author

Allow Aloe to Do the Work: <i>Aloe vera</i> Constrains Growth of Bladder Cancer Cells and Modulates Expression of Key Costimulatory Molecules.

Anticancer research·2026
Same author

Rewiring immunity: CAR-T cells as a paradigm shift in hematologic oncology.

Critical reviews in oncology/hematology·2026
Same author

Review of Risk Factors for Opioid Misuse and Addiction Following Traumatic Injury.

Healthcare (Basel, Switzerland)·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

Into the Future: Fighting Melanoma with Immunity.

Derek A Corica1, Scott D Bell1, Peyton J Miller1

  • 1Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA.

Cancers
|December 17, 2024
PubMed
Summary

Immunotherapy, including immune checkpoint inhibitors and tumor vaccines, offers new treatment options for advanced melanoma. While toxicities exist, these immunotherapies harness the immune system for effective tumor destruction and potential remission.

Keywords:
melanomamelanoma immunotherapymelanoma treatment

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

Related Experiment Videos

Last Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

Area of Science:

  • Oncology
  • Immunology

Background:

  • Immunotherapy presents a novel treatment strategy for advanced melanoma, particularly for patients with tumor progression.
  • It leverages the patient's own immune system to combat cancer cells.

Purpose of the Study:

  • To review the efficacy and mechanisms of common immunotherapies used in melanoma treatment.
  • To highlight the potential of immunotherapy in inducing tumor destruction and remission.

Main Methods:

  • Discussion of immune checkpoint inhibitors that block T-cell inactivation pathways.
  • Explanation of tumor-infiltrating lymphocyte (TIL) therapy, an adoptive cell transfer method.
  • Overview of tumor vaccines that present tumor antigens to activate immune responses.
  • Description of cytokine therapy to support T-cell expansion.

Main Results:

  • Immunotherapies, including immune checkpoint inhibitors, TIL therapy, tumor vaccines, and cytokine therapy, are effective in treating melanoma.
  • These methods utilize the immune system to induce cytotoxic responses against tumors.
  • Immunotherapy has shown efficacy in achieving remission in melanoma patients.

Conclusions:

  • Immunotherapy provides a promising avenue for advanced melanoma treatment, offering alternatives post-progression.
  • Despite potential toxicities, immunotherapy demonstrates significant efficacy in melanoma management.
  • Key immunotherapeutic approaches include immune checkpoint inhibitors, TIL therapy, tumor vaccines, and cytokine therapy.